These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9467569

  • 1. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
    Ward LS, Brenta G, Medvedovic M, Fagin JA.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K, Delahunt B, Wang XL, McIver B, Hay ID, Goellner JR, Eberhardt NL, Grebe SK.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [Abstract] [Full Text] [Related]

  • 6. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
    Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells SA, Goodfellow PJ.
    Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
    Trovato M, Fraggetta F, Villari D, Batolo D, Mackey K, Trimarchi F, Benvenga S.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
    [Abstract] [Full Text] [Related]

  • 9. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
    Matsuo K, Tang SH, Fagin JA.
    Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M.
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [Abstract] [Full Text] [Related]

  • 12. Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p, and 22q.
    Kitamura Y, Shimizu K, Ito K, Tanaka S, Emi M.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4268-72. PubMed ID: 11549660
    [Abstract] [Full Text] [Related]

  • 13. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C.
    Cancer Res; 1997 Nov 01; 57(21):4710-3. PubMed ID: 9354427
    [Abstract] [Full Text] [Related]

  • 14. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ, Marsh DJ, Zedenius J, Dwight T, Delbridge L, Robinson BG, Eng C.
    Genes Chromosomes Cancer; 1999 Dec 01; 26(4):322-8. PubMed ID: 10534767
    [Abstract] [Full Text] [Related]

  • 15. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS, Nelson M, McIver B, Hay ID, Goellner JR, Grant CS, Eberhardt NL, Smith DI.
    Oncogene; 1998 Aug 13; 17(6):789-93. PubMed ID: 9715281
    [Abstract] [Full Text] [Related]

  • 16. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
    Kadota M, Tamaki Y, Sekimoto M, Fujiwara Y, Aritake N, Hasegawa S, Kobayashi T, Ikeda T, Horii A, Monden M.
    Oncol Rep; 2003 Aug 13; 10(1):35-8. PubMed ID: 12469141
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity in 73 human thyroid tumors.
    Wozniak A, Wiench M, Olejniczak A, Wloch J, Lachinski A, Lange D, Olczyk T, Jarzab B, Limon J.
    Neuro Endocrinol Lett; 2005 Oct 13; 26(5):521-5. PubMed ID: 16264407
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 19. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD.
    Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412
    [Abstract] [Full Text] [Related]

  • 20. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas.
    Sarquis MS, Weber F, Shen L, Broelsch CE, Jhiang SM, Zedenius J, Frilling A, Eng C.
    J Clin Endocrinol Metab; 2006 Jan 15; 91(1):262-9. PubMed ID: 16249278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.